Healthtech
Board Management for Healthtech Startups
A healthtech board is reading three timelines at once — clinical, regulatory, and commercial — and they do not move at the same speed or resolve on the same schedule.
At a Glance
- Progress measured in
- Milestones as well as metrics
- Parallel tracks
- Clinical, regulatory, commercial
- Cycle length
- Often multi-year
- Programmatic access
- Scoped API tokens (21 scopes)
The Scenario
Healthtech startups report against milestones rather than only against metrics. A quarter's real progress may be a completed study enrolment, a submission accepted for review, or a health-system pilot converting to a contract — none of which fit a growth chart. The board is simultaneously tracking a commercial line that behaves like normal software, a regulatory line measured in submissions and responses, and a clinical line measured in evidence. The reporting problem is that these three live in different systems and different heads, and they get flattened into one deck each quarter by hand.
Where It Breaks Down
-
Progress is milestones, not a growth curve
The quarter's most important result may be a regulatory acceptance or an enrolment target, which a metrics-shaped deck represents poorly.
-
Three timelines, three owners
Clinical, regulatory, and commercial progress are owned by different people and tracked in different systems, then merged manually.
-
Long cycles need durable context
A decision taken two years ago still governs a submission in flight, and the reasoning behind it has to remain retrievable.
-
Sensitivity varies by material
Clinical and regulatory material is circulated ad hoc, with no durable record of which version informed which decision.
How I'mBoard Helps
Milestones tracked as action items
Action items and decisions are typed objects with owners and states, so milestone progress is a tracked record rather than a bullet that reappears each quarter.
Parallel tracks, one structure
Clinical, regulatory, and commercial reporting use the same typed entities, so merging three timelines is not a quarterly manual exercise.
Context that survives the cycle
Multi-year decision history stays queryable through the API, the CLI, or an assistant over MCP — which matters when cycles outlast the people who ran them.
Narrow credentials for integrations
21 API token scopes keep any integration or agent credential scoped to what it needs, rather than granting blanket read access to the workspace.
Frequently Asked Questions
What should a healthtech startup report to its board?
A healthtech board typically reads three tracks in parallel: clinical progress measured in evidence and study milestones, regulatory progress measured in submissions and responses, and commercial progress measured in the usual pipeline and revenue terms. The reporting difficulty is that these three run on different clocks and are owned by different people.
Why are healthtech board meetings harder to prepare than SaaS ones?
Because progress is not a single curve. A quarter's most consequential result may be an accepted submission or a completed enrolment rather than a revenue movement, and the material comes from three separate owners and systems. Flattening those into one coherent deck each quarter is manual merge work, not just data pulling.
How do you keep board context across a multi-year clinical or regulatory cycle?
By making the reasoning retrievable rather than remembered. When decisions are stored as typed entities against the meeting they were taken in, a decision from two years ago that still governs a submission in flight can be queried directly — which matters most when the people who took it have moved on.
Can healthtech boards restrict who sees clinical material?
I'mBoard's distribution is dual-track: stakeholders connected to the workspace read board data programmatically, and stakeholders who are not connected receive a PDF and can reply by email. Programmatic access is governed by API tokens carrying 19 distinct scopes, which narrow what any given integration or agent can read.
Start With Structure, Not Slides
$30 per seat per month, three-seat minimum. 14-day free trial, no credit card required.